ADMA Biologics Inc. (ADMA)

NASDAQ: ADMA · Real-Time Price · USD

23.31

-0.49 (-2.06%)

At close: May 01, 2025, 3:59 PM

23.14

-0.73%

After-hours: May 01, 2025, 04:10 PM EDT

ADMA Biologics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	426.45M	258.21M	154.08M	80.94M	42.22M	29.35M	16.99M	22.76M	10.66M
Cost of Revenue	206.9M	169.27M	118.81M	79.77M	61.29M	39.5M	42.19M	29.16M	6.36M
Gross Profit	219.55M	88.94M	35.27M	1.17M	-19.07M	-10.16M	-25.21M	-6.4M	4.3M
Operating Income	138.98M	21.63M	-39.37M	-58.37M	-64.91M	-41.42M	-60.29M	-39.31M	-17.33M
Interest Income	2.1M	1.62M	44.83K	34.53K	288.13K	800.78K	195.4K	57.23K	50.32K
Pretax Income	125.71M	-28.24M	-65.9M	-71.65M	-75.75M	-48.28M	-65.74M	-43.76M	-19.52M
Net Income	197.67M	-28.24M	-85.18M	-84.45M	-87.61M	-57.05M	-65.74M	-43.76M	-19.52M
Selling & General & Admin	74.12M	59.02M	52.46M	42.9M	35.05M	25.91M	22.5M	18.09M	8.49M
Research & Development	1.81M	3.3M	3.61M	3.65M	5.91M	2.34M	3.93M	6.23M	7.69M
Other Expenses	4.63M	4.99M	18.56M	13M	4.89M	3.01M	-127.12K	-10.14K	4.5K
Operating Expenses	80.57M	67.31M	74.63M	59.55M	45.84M	31.27M	35.08M	32.06M	21.63M
Interest Expense	13.93M	25.03M	19.28M	13.06M	11.99M	8.99M	5.52M	3.29M	2.24M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	287.47M	236.58M	193.44M	139.32M	107.13M	70.77M	77.27M	61.23M	27.99M
Income Tax Expense	-71.96M	n/a	19.28M	12.81M	11.86M	8.77M	5.45M	4.45M	2.18M
Shares Outstanding (Basic)	233.08M	223.98M	197.87M	139.58M	86.15M	54.35M	45.19M	22.9M	12.15M
Shares Outstanding (Diluted)	243.34M	223.98M	197.87M	139.58M	86.15M	54.35M	45.19M	22.9M	12.15M
EPS (Basic)	0.85	-0.13	-0.43	-0.61	-1.02	-1.05	-1.45	-1.91	-1.61
EPS (Diluted)	0.81	-0.13	-0.43	-0.61	-1.02	-1.05	-1.45	-1.91	-1.61
EBITDA	147.69M	5.12M	-39.72M	-53.33M	-59.82M	-36.03M	-56.77M	-39.31M	-16.81M
EBIT	139.64M	-3.21M	-46.63M	-58.59M	-63.76M	-39.29M	-60.22M	-40.47M	-17.28M
Depreciation & Amortization	8.04M	8.33M	7.11M	5.5M	3.94M	3.26M	3.45M	1.23M	469.58K